Aims/background-Oxidative damage has been proposed to be involved in the pathogenesis of age-related macular degeneration (ARMD). (BrJ Ophthalmol 1996; 80: 445-450) 
Age-related macular degeneration (ARMD) is the most common cause of blindness in individuals over 55 years of age in the USA.' It is expected to become of greater public health concern as the proportion of elderly people in the population increases over the next century.
The exact aetiology of ARMD is not known. Oxidative damage has been implicated in the pathogenesis of the disease,24 but the precise role of the damaging effects of reactive oxygen species in development and progression of the disorder remains to be fully elucidated. A haematogenous basis for development of ARMD, which involves oxidative damage, has been proposed by Gottsch et al, 5 who suggest that development of ARMD is caused by chronic light exposure with direct choriocapillaris damage. Further evidence for involvement of blood factors is suggested by the finding that a high plasma antioxidant index has a protective effect in ARMD. 6 In addition, increased dietary consumption of foods high in carotenoids, which are known to protect against singlet oxygen mediated oxidative damage, has been implicated in protecting against development of severe ARMD. 7 The exact role of blood antioxidant substances in disease development and progression remains to be fully elucidated.
Enzymes including superoxide dismutase, catalase, glucose-6-phosphate dehydrogenase, glutathione peroxidase, and glutathione reductase are involved in protecting against oxidative damage. Previous reports suggest that blood levels of antioxidant enzymes may be lower in individuals with ARMD than in controls. Low glutathione peroxidase,89 glutathione reductase, 8 and superoxide dismutase9 activities in red blood cells of ARMD patients compared with age-matched controls have been identified.
In this report, red blood cell antioxidant enzyme activity in patients with ARMD is further evaluated.
Patients and methods Over a 6 month period, 54 subjects were referred to one of the authors (MAD) for evaluation of ARMD and recruited into the study at the time of their clinic visit. Twelve similarly aged subjects without ARMD were recruited into the study for comparison All subjects underwent the same ophthalmic examination. Measurements of best corrected visual acuity, slit-lamp examination, and applanation tonometry were performed for each subject. Non-contact lens biomicroscopy was performed on each subject (by MAD). Fundus photography was performed for most subjects, and fluorescein angiography was performed when clinically indicated. Severity of aging maculopathy for each eye was evaluated according to a modification of the eligibility scale used in the ongoing multicentre clinical trial of the Age-Related Eye Disease Study (AREDS).10 In this grading system, we define five grades (Table 1) . Twelve patients were classified as grade 1. Grade 1 patients are The blood sample was centrifuged at 3000 g for 10 minutes to separate plasma and buffy coat from red blood cells. The plasma and buffy coat were carefully removed from the red blood cells using a glass pipette. Then 3 ml of deionised water were added to the red blood cells to induce haemolysis. The tube was gently vortexed. The sample was then centrifuged at 13 500 g for 5 minutes to separate the haemolysate from the pellet of red blood cell membranes.
Assays of superoxide dismutase, catalase, glucose-6-phosphate dehydrogenase, glutathione peroxidase, and glutathione reductase were performed immediately using the red blood cell haemolysate. Spectrophotometric determination of enzyme activity was carried out using a Shimadzu UV-260 spectrophotometer, 3 ml quartz cuvettes, path length 10 mm. All assays were performed at 25°C. Unless otherwise specified, all reagents were obtained from Sigma Chemical Company (St Louis, MO, USA).
Superoxide dismutase activity was determined based on the kinetic assay of McCord and Fridovich,12 which is based on the inhibition of cytochrome c reduction by xanthine oxidase in the presence of substrate. The reaction mixture consisted of 2X 10-5 M cytochrome c, 100 ,uM xanthine in 0.05 M phosphate buffer, pH 7-8, containing lX 0-4 M EDTA. The increase in absorbance at 550 nm was measured after addition of xanthine oxidase once measurement of baseline absorbance had been noted to verify stability. The assay was based on the inhibition of cytochrome c reduction by xanthine oxidase in the presence of 10 ,ul of haemolysate.
Definition of enzyme activity unit was as described by McCord and Fridovich,12 and activity was expressed as units per mg haemoglobin.
Catalase assay was based on the method of Beers and Sizer,13 in which decrease in ultraviolet absorption of hydrogen peroxide at 230 nm is measured spectrophotometrically as a function of time. The reaction mixture consisted of 9-20 mM hydrogen peroxide in 0-05 M phosphate buffer, pH 7 0. The decrease in absorbance over 4 minutes was followed after the addition of 20 ,ul of a 1:2000 dilution of haemolysate. Enzyme activity was measured as pumol hydrogen peroxide consumed per mg haemoglobin per minute.
Glucose-6-phosphate dehydrogenase activity was determined based on the method described by Kirkman, 14 in which the rate of generation of reduced nicotinamide adenine dinucleotide phosphate (NADPH) was measured as an increase in absorbance at 340 nm. The reaction mixture consisted of a final concentration of 0-06 mM glucose-6-phosphate, 0-20 mM nicotinamide adenine dinucleotide phosphate (NADP+), and 0 10 M magnesium chloride in 0.10 M TRIS-HCI, pH 8- Glutathione reductase activity was based on a modification of the procedure for glutathione peroxidase, in which oxidation of NADPH is measured as a decrease in absorption at 340 nm over time. The reaction mixture included 5 0 mM oxidised glutathione and 0-28 mM NADPH in 0 05 M phosphate buffer, pH 7 0, containing 0 10 mM EDTA. The reaction was initiated by the addition of 10 RI of a 1:4 dilution of haemolysate, and decrease in absorbance at 340 nm was followed over a period of 3-4 minutes. Spontaneous breakdown of NADPH was measured before addition of haemolysate, and subtracted from the final rate. Enzyme activity was expressed as in the glutathione peroxidase assay.
All enzyme assays were performed in duplicate. Activities were calculated to account for SOD activity 6 7 Figure tion to quench free radicals and thus prevent propagation of the damaging reactions. In )d cell enzyme activity and disease severity. addition, antioxidant enzymes such as superre was no significant association for any of oxide dismutase catalyse reactions which enzymes (Table 3 ). In addition, none of the prevent the damaging reactions induced by ariables had a significant impact on anti-free radicals. Catalase and the glutathione lant enzyme activity. Ordinal regression enzyme system function to prevent the lysis was performed to evaluate the predic-damaging effects of hydrogen peroxide. value of antioxidant enzyme activity for Glucose-6-phosphate dehydrogenase particii enzyme on severity of ARMD, and once pates indirectly by catalysing the generation of in no significant association was found.
reduced nicotinamide adenine dinucleotide n a separate analysis, three new stages were phosphate, a necessary cofactor for the protecned by combining previously defined tive glutathione system. ,es of disease: stage 1 remained as a single
The protective effect of antioxidant sub-1 (level 1); stages 2 and 3 were combined stances in ARMD is suggested by the finding el 2); and stages 4 and 5 were combined that a high blood antioxidant index (composed el 3). Once again there was no significant of blood levels of vitamins E, C, selenium, and )ciation between severity of ARMD and carotenoids) is associated with a decreased risk ioxidant enzyme activity when stages were for development of neovascular ARMD.6 aped into these new levels.
These results imply that oxidative damage is involved in development of neovascular ARMD. However, there is no conclusive cussion evidence that an increased susceptibility to dative damage is a form of tissue injury oxidative stress exists in patients with the ch is initiated by reactive oxygen species disease. Concerning treatment options, further wn as free radicals. These reactive mole-studies (such as the National Eye Institute 
